Approval · Notice of Compliance 27996 · 2022
VASCEPA: Notice of Compliance 27996
Issued April 21, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27996
- Date
- April 21, 2022
- Company
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Clinical Pharmacology updates to the Product Monograph Conversion of Product Monograph to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASCEPA | Not yet assigned | — |
Medicinal ingredients
- ICOSAPENT ETHYL 1 G per CAP